Search results with tag "Annex 2"
MEDICAL DEVICE REGULATION PRE-MARKET …
www.who.intClassification of Medical Devices EU US JAPAN Class I =Annex 7 Class IIa =Annex 7 + Annex 2 or (Annex 4 or 5 or 6) Class IIb -Annex 7 + Annex 2 or (Annex
Technical Information - ClassNK
www.classnk.or.jpMEPC 70/18/Add.1 Annex 2, page 1 https://edocs.imo.org/Final Documents/English/MEPC 70-18-ADD.1 (E).docx ANNEX 2 . RESOLUTION MEPC.277(70) (Adopted on 28 October 2016)
Guidelines on the international packaging and shipping of ...
www.who.int105 3.2. Labelling for tertiary packages (Insulated packages) 106 . 107 4. International Shipping Procedures 108 . ... Annex 2: Shake test protocol 117 . Annex 3: List of contact points for NRAs ... classification of vaccines according to their Classof shipping box, please go to Annex XX Class Type of vaccine (see ...
GUIDELINES ON OUTSOURCING - Monetary Authority of ...
www.mas.gov.sgGUIDELINES ON OUTSOURCING 2 2.2 Annex 1 provides a non-exhaustive list of examples of outsourcing arrangements to which these Guidelines are applicable, and arrangements that are not intended to be subject
FREE TRADE AGREEMENT BETWEEN THE GOVERNMENT OF …
fta.mofcom.gov.cnArticle 2.4: Reduction or Elimination of Customs Duties 1. Except as otherwise provided in this Agreement, each Party shall progressively reduce or eliminate its customs duties on originating goods of the other Party in accordance with its Schedule to Annex 2-A. 2. On the request of either Party, the Parties shall consult to consider possibility of
Recommendations 01/2020 on measures that supplement ...
edpb.europa.euThese recommendations contain (in Annex 2) a non-exhaustive list of examples of supplementary measures with some of the conditions they would require to be effective. As is the case for the appropriate safeguards contained in the Article 46 transfer tools, some supplementary measures may be effective in some countries, but not necessarily in ...
supplementing Regulation (EU) No 600/2014 of the European ...
ec.europa.eu2 ANNEX I Description of the type of system and the related information to be made public in accordance with Article 2 Information to be made public in accordance ...
STABILITY TESTING OF ACTIVE PHARMACEUTICAL …
www.who.intWorking document QAS/17.694 page 3 Introduction and background36 37 38 The Stability testing of active pharmaceutical ingredients and finished 39 pharmaceutical products was published as Annex 2 in the WHO Technical 40 Report Series, No. 953, 2009 (1). 41 42 These regulatory guidelines seek to exemplify the core stability data package 43 required for registration of active pharmaceutical ...
Annex 2 W HO good manufacturing practices for active ...
www.who.intAnnex 2 W HO good manufacturing practices for active pharmaceutical ingredients 1. Introduction 1.1 Objective 1.2 Regulatory applicability 1.3 Scope 2. Quality management 2.1 Principles 2.2 Responsibilities of the quality unit(s) 2.3 Responsibility for production activities 2.4 Internal audits (self-inspection) 2.5 Product quality review 3 ...
Annex 5 - WHO
www.who.intAnnex 5 Recommendations to assure the quality, safety and efficacy of tetanus vaccines (adsorbed) Replacement of Annex 2 of WHO Technical Report Series, No. 800, and Annex 5 of WHO Technical Report Series, No. 927 Introduction 273 Scope of the Recommendations 279 General considerations 279 Part A. Manufacturing recommendations 284 A.1 ...
2017 DSE Timetable (Annex 2) - hkeaa.edu.hk
www.hkeaa.edu.hk2017 年 香 港 中 學 文 憑 考 試 HONG KONG DIPLOMA OF SECONDARY EDUCATION EXAMINATION 2017 考試時間表 TIMETABLE 日期Date 時間Time Subject / Paper 科目／試卷 三月三十一日（星期五） 8:30 - 12:30 Visual Arts 1,2 視覺藝術 （一）及（二）
Annex 2 WHO good manufacturing practices: water …
www.who.intAnnex 2 69 1.2.2 Control of the quality of water throughout the production, storage and dis- tribution processes, including microbiological and chemical quality, is a major con - cern. Unlike other product and process ingredients, water is usually drawn from a
ANNEX 2. LIST OF PROCEDURE CASE RATES FIRST CASE …
www.philhealth.gov.phShaving of epidermal or dermal lesion, single lesion, trunk, arms or legs; lesion diameter 0.6 to 1.0 cm 3,700 1,344 2,356 11302 Shaving of epidermal or dermal lesion, single lesion, trunk, arms or legs; lesion diameter 1.1 to 2.0 cm
Annex 2 - WHO
www.who.int49 Annex 2 Recommendations to assure the quality, safety and efficacy of poliomyelitis vaccines (oral, live, attenuated) Replacement of Annex 1 …
Annex 2 WHO good practices for pharmaceutical …
www.who.intAnnex 2 WHO good practices for pharmaceutical microbiology laboratories Background The WHO Expert Committee on Specifi cations for Pharmaceutical Preparations adopted in 2009 a revised version of the Good practices for pharmaceutical quality control laboratories (1). During the inspections carried out when prequalifying laboratories, the
Annex 2 - Roles and duties of Statutory Officers
assets.publishing.service.gov.ukAnnex 2 - Roles and duties of Statutory Officers . Every relevant local authority, namely: • County Councils; • County Borough Councils; • District Councils;
Annex 2 - World Health Organization
www.who.intAnnex 2 63 While the choice of the tools to support the QRM approach is optional and may vary, the tools chosen need to be appropriate for the intended use.
Similar queries
MEDICAL DEVICE REGULATION PRE-MARKET, Classification, Annex, Annex 2, Technical Information, MEPC 70, ANNEX 2 . RESOLUTION MEPC.277(70) Adopted on, Labelling, Guidelines, 2 ANNEX, Recommendations, STABILITY TESTING OF ACTIVE PHARMACEUTICAL, Stability testing of active pharmaceutical ingredients and, Pharmaceutical, Stability, Of active pharmaceutical, 2017 DSE Timetable (Annex 2) - hkeaa.edu.hk, 2017, HONG KONG, TIMETABLE, Annex 2 WHO good, Practices, ANNEX 2. LIST OF PROCEDURE CASE RATES, Legs, Annex 2 Recommendations, Practices for pharmaceutical microbiology laboratories Background, Revised, World Health Organization